Skip to content
GLP-1 Scorecard
Menu
Graded #353

SexyMD

Every price SexyMD advertises is a 48-week commitment rate, and the month-to-month figures behind them are $70 higher on each molecule.

Visit SexyMDWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$269/mo (four-week plan; the $199 in every headline is the 48-week rate)
Tirzepatide
$369/mo (four-week plan; the $299 in every headline is the 48-week rate)
Coverage
47 states (all except Arkansas, Mississippi and New Jersey)
Brand-name
Compounded only

Weigh SexyMD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because SexyMD dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value38/100
Dose & formulation64/100
Clinical oversight73/100
Labs & monitoring52/100
Fulfillment85/100
Contract terms67/100

Strengths

  • Publishes an exact exclusion list — all states except Arkansas, Mississippi and New Jersey — rather than a nationwide claim
  • States both compounding classes in the Terms, so the class question is answered even though the pharmacy is not named
  • Names the prescribing entity and the professional corporation behind it
  • Sells two microdose products with their own published price tables rather than only as a discount tier

Where it loses points

  • Every headline price is the 48-week commitment rate: $199 against a month-to-month figure of $269, and $299 against $369, with an asterisk that resolves to no footnote
  • The same footer, on every page, says both that the service is available in all 50 states and that it is available in all states except three
  • The two microdose products publish identical prices for their 4-, 8- and 12-week plans, in the same table format that carries real tiers elsewhere
  • The microdose page contradicts itself on dosing frequency inside a single page
  • Three unsourced and mutually inconsistent social-proof figures appear across the homepage, the footer and the product pages
  • The checkout claims two patient counts for a single day that together exceed the total the site's own badge claims
  • No pharmacy is named, and what the price includes is never itemized on any product page

Bottom line — Grade C

Best for: Shoppers who intend to stay a full year and want a microdose option, and who will read the plan table rather than the headline.

Ranked #353 of 536 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest SexyMD — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect SexyMD's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on SexyMD's site. Not medical advice; see our disclosure.

← Back to the scorecard